P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DARA) IN ELDERLY FRAIL RELAPSING MYELOMA (RRMM) PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018-02 OF THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM).
M. Macro,
C. Touzeau,
C. Mariette,
S. Manier,
S. Brechignac,
L. Vincent,
B. Hebraud,
O. Decaux,
S. Schulmann,
C. Lenoir,
P. Godmer,
A. Farge,
L. Peyro Saint Paul,
J.-J. Parienti,
X. Leleu
Affiliations
M. Macro
1 HEMATOLOGY IHBN, University Hospital, CAEN
C. Touzeau
2 HEMATOLOGY, University Hospital, Nantes
C. Mariette
3 HEMATOLOGY, University Hospital, Grenoble
S. Manier
4 Hematology, University Hospital, Lille
S. Brechignac
5 Hematology, University Hospital, Paris
L. Vincent
6 Hematology, University Hospital, Montpellier
B. Hebraud
7 Hematology, University Hospital, Toulouse
O. Decaux
8 Hematology, University Hospital, Rennes
S. Schulmann
9 Hematology, University Hospital, Nancy
C. Lenoir
10 Hematology, Private Hospital, Bordeaux
P. Godmer
11 Hematology, Community Hospital, Vannes
A. Farge
12 Hematology
L. Peyro Saint Paul
13 Clinical Research, University Hospital, CAEN
J.-J. Parienti
13 Clinical Research, University Hospital, CAEN
X. Leleu
14 Hematology, University Hospital, Poitiers, France
